Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation

To characterize bone marrow failure with del(13q), we reviewed clinical records of 22 bone marrow failure patients possessing del(13q) alone or del(13q) plus other abnormalities. All del(13q) patients were diagnosed with myelodysplastic syndrome-unclassified due to the absence of apparent dysplasia....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hosokawa, Kohei, Katagiri, Takamasa, Sugimori, Naomi, Ishiyama, Ken, Sasaki, Yumi, Seiki, Yu, Sato-Otsubo, Aiko, Sanada, Masashi, Ogawa, Seishi, Nakao, Shinji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2012
Gaiak:
Original Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590091/
https://ncbi.nlm.nih.gov/pubmed/22689682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.061127
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak